Private Equity


As an anchor investor, we focus on projects that are in line with our company’s core value— to advance and better the society. As such, we look for investment opportunities and partnerships in the new economy and life science industries which include companies in FinTech, TMT, sharing economy, and biotech, while remaining open to opportunities in the consumer, education and travel industries.

Private Equity


  • A leading Fintech group, using financial technology to build a top-tier virtual bank and lending platform
  • 2019 revenue totaled US$374.6 million (2018: $313.7m) with a 19.4% YoY growth rate; Core business remains profitable under the COVID-19 pandemic
  • Ranked No.1 in Growth Champions of the Greater Bay Area 2020 by South China Morning Post
  • Received the Fintech Development Leader Diamond Award in Lending Tech from the IFTA Institute of Financial Technologists of Asia


  • Leading biotech company that focuses on developing RNAi therapeutics for treatment of cancer & fibrosis diseases
  • Clinical stage biopharmaceutical company focused on oncology and fibrosis indications
  • Key differentiating feature is the proprietary Polypeptide Nano-Particle (PNP) technology for small interfering RNA (siRNA) drug delivery
  • Technology allows accessing the tumor micro-environment (TME) as well as various cell types in the liver

Day Day Cook

  • One of Asia’s largest O2O Lifestyle & Cooking platforms
  • Operator of an online cooking recipe-sharing platform receiving 475 million monthly views, with a 70% month-on-month increase during the COVID-19 pandemic 
  • Venture capitalists include Alibaba and K11 Investment
  • Has e-commerce platforms in Mainland China

Westminster College

  • A top school in the UK, with A-level results and Oxbridge rate both ranking top three in the UK
  • With plans to open six school branches in Mainland China